Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2022-03-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
独立董事关于相关事项的事前确认函
Regulatory Filings Classification · 95% confidence The document is a letter from independent directors providing prior confirmation on related party transactions and financial business dealings for the year 2022. It includes opinions on the fairness and compliance of these transactions and states that the matters will be submitted to the board for approval. The document is short (851 characters) and does not contain financial statements or detailed financial data. It is a regulatory or compliance-related confirmation rather than a full report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS) as it is a formal attestation related to corporate governance and compliance.
2022-03-21 Chinese
关于中粮集团承诺解决同业竞争、瑕疵资产事项延期的公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement by COFCO Biochemical Co., Ltd. regarding the extension of commitments made by its controlling shareholder, COFCO Group, to resolve issues related to business competition and defective assets. It references prior regulatory approvals and commitments tied to a major asset restructuring completed in 2018. The content focuses on the status of these commitments, the extension of deadlines, the impact on the company, board meeting resolutions, and independent directors' opinions. There are no financial statements, earnings data, or detailed financial analysis present. The document is an official company announcement about governance and compliance matters related to prior commitments and their extension, rather than a full report or financial filing. It is also relatively short (4002 characters) and structured as a formal public notice. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-03-21 Chinese
八届董事会2022年第三次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the company's eighth board of directors' third extraordinary meeting in 2022. It details attendance, voting results on various proposals, and references related announcements published elsewhere. The content focuses on board meeting decisions and voting outcomes rather than full financial data or detailed management reports. The document is relatively short (1803 characters) and serves as an official notice of board resolutions rather than a comprehensive report or presentation. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2022-03-21 Chinese
关于公司与中粮财务有限责任公司办理存贷款等金融业务的关联交易公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding related party transactions between the company and a related financial entity controlled by the same parent group. It details the nature of the transactions, approval by the board and independent directors, risk control measures, and the impact on the company. It does not contain financial statements or detailed financial performance data. The document is a formal disclosure of a related party transaction, which is a regulatory announcement rather than a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS). The document length is about 2585 characters, which is relatively short and consistent with an announcement rather than a full report.
2022-03-21 Chinese
关于召开公司2022年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2022 second extraordinary general meeting of shareholders for a company, including meeting time, location, agenda items, voting procedures, and proxy forms. It does not contain financial statements or results, nor is it a transcript or presentation. It is a formal announcement to shareholders about the meeting and voting process. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides information and requests votes for meetings. The document length is under 5,000 characters, but it is not merely announcing a report publication; it is the actual meeting notice and related materials. Therefore, the correct classification is PSI with high confidence.
2022-03-21 Chinese
关于部分董事、高级管理人员减持股份的预披露公告
Director's Dealing Classification · 95% confidence The document is a pre-disclosure announcement regarding planned share reductions by certain directors and senior management of the company. It details the number of shares to be sold, the reasons for the sale, the timing, and compliance with relevant regulations. This type of document is a report of personal share transactions by company directors and executives, which fits the definition of a Director's Dealing filing. The document is not an annual report, earnings release, or any other financial report, nor is it an announcement of a report publication. Therefore, the correct classification is DIRS (Director's Dealing). The document length and content support a high confidence in this classification.
2022-02-25 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.